Keywords: Eye disorders, Market forecasts, Ophthalmic medicine, Regeneron, Eylea, Visiongain
Eye disorders drug sales set to reach $23.8 billion in 2016, predicts Visiongain
Article | 18 October 2012
Total worldwide revenues from drugs to treat eye disorders will reach $23.8 billion in 2016, according to a new report from business ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- Is failure to adopt business process management putting the pharma industry at risk?
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
